Simple blood tests can point clinicians toward the right diagnosis in infants with cholestasis.
Abdulrahman A. Al-Hussaini and Muhammed Salman Bashir
Reviewing infants with cholestasis seen over more than a decade, this study examined how routine biochemical tests at first presentation related to eventual diagnosis. Patterns in liver enzymes, lactate, ferritin, and alpha-fetoprotein helped distinguish categories such as biliary obstruction, mitochondrial disease, and metabolic disorders, even though no single test was diagnostic on its own. The authors present these markers as practical red flags for triaging which specialized investigations to pursue first.
- The question: Can simple biochemical tests at first presentation point toward the cause of cholestasis in an infant?
- The study: Researchers reviewed infants with cholestasis seen over more than a decade, and compared early test results with the final diagnosis.
- The finding: Patterns in liver enzymes, lactate, ferritin, and alpha-fetoprotein helped distinguish biliary obstruction, mitochondrial disease, and metabolic disorders.
- The nuance: Still, no single test was diagnostic on its own, which is why the overall pattern matters more than any one value.
Takeaway: treat these markers as red flags that guide which investigations to pursue first.
Narrated (standard AI voice, not a cloned voice) with burned-in captions matching the narration word-for-word — safe to watch muted. Built from this article’s SGA Briefing only.
This links to the publisher’s open-access copy of record. A self-hosted PDF will appear here once one is on file.